Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539942 · ClinicalTrials.gov registry record · Phase 3
Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
A Phase 3 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 3
- Development phase
- 7
- Enrollment target
NCT00539942: Clinical Trial Phase 3 study, sponsored by University of Alabama at Birmingham.
NCT00539942 is a Phase 3 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 7 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00539942, a Phase 3 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a randomized trial to compare intermittent compression devices with or without post-operative Arixtra (fondaparinux sodium) in women undergoing major abdominal surgery for known or presumed gynecologic malignancies. This trial seeks to determine if there is a difference in the rate of deep venous thrombosis between these two groups.
Primary Outcome
Deep venous thromboembolism (DVT) rates are determined from lower extremity doppler ultrasound measurements.
Interventions
- DRUG Arixtra (fondaparinux sodium)
- DEVICE Intermittent compression devices (ICD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-06 |
| Phase | Phase 3 |
Why NCT00539942 stopped before completion
NCT00539942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Arixtra (fondaparinux sodium) is the first listed.
NCT00539942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00539942 about?
NCT00539942 is a clinical study titled "Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy". This is a randomized trial to compare intermittent compression devices with or without post-operative Arixtra (fondaparinux sodium) in women undergoing major abdominal surgery for known or presumed gynecologic malignancies. This trial seeks to determine if there is a difference in the rate of deep v...
What is the current status of trial NCT00539942?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 7 participants. The study started on 2007-04. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00539942?
The interventions under investigation include: Arixtra (fondaparinux sodium) (DRUG), Intermittent compression devices (ICD) (DEVICE).
Who is sponsoring clinical trial NCT00539942?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00539942's enrollment target sits among peer trials
7 1995th of 2000 higher than 6 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia